These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 4058785)
21. Ethosuximide and tremor in Parkinson's disease: a pilot study. Pourcher E; Gomez-Mancilla B; Bédard PJ Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060 [TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of the antidepressants: maprotiline and amitriptyline. A double-blind controlled trial. Marais GF S Afr Med J; 1974 Jul; 48(36):1530-2. PubMed ID: 4608286 [No Abstract] [Full Text] [Related]
23. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. Fox MW; Ahlskog JE; Kelly PJ J Neurosurg; 1991 Nov; 75(5):723-30. PubMed ID: 1919694 [TBL] [Abstract][Full Text] [Related]
24. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia. Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467 [TBL] [Abstract][Full Text] [Related]
25. [Clinical experience and cardiovascular and respiratory effects of intravenous injection of azabicyclane]. Morikawa S; Iwai S Masui; 1970 Sep; 19(9):962-7. PubMed ID: 5466642 [No Abstract] [Full Text] [Related]
26. [Action of amantadine on parkinsonian tremor]. Agnoli A; Casacchia M; Ruggieri S; Volante F; Accornero N Minerva Med; 1971 Oct; 62(82):3990-3. PubMed ID: 5125061 [No Abstract] [Full Text] [Related]
31. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease]. de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286 [TBL] [Abstract][Full Text] [Related]
32. Parkinsonian and essential tremors: different entities or different manifestations of the same disorder? Lücking CH; Köster B; Guschlbauer B; Lauk M; Timmer J Adv Neurol; 1999; 80():335-9. PubMed ID: 10410738 [No Abstract] [Full Text] [Related]
33. [Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]. Schneider E; Fischer PA; Clemens R; Balzereit F; Fünfgeld EW; Haase HJ Dtsch Med Wochenschr; 1984 Jun; 109(25):987-90. PubMed ID: 6734455 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacological treatment of parkinsonian tremor]. Yokochi F Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452 [TBL] [Abstract][Full Text] [Related]
35. Amantidine for relief of Parkinsonian tremor. Lutz EG J Med Soc N J; 1971 Sep; 68(9):747-51. PubMed ID: 5285959 [No Abstract] [Full Text] [Related]
36. [Piribedil in the treatment of Parkinson disease (author's transl)]. Nardini M; Sciannandrone R; Fieschi C; De Simone G Riv Patol Nerv Ment; 1975; 96(2):103-10. PubMed ID: 778998 [TBL] [Abstract][Full Text] [Related]
37. [Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved]. MMW Fortschr Med; 2002 May; Suppl 2():88. PubMed ID: 12070869 [No Abstract] [Full Text] [Related]
38. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease. Künig G; Pogarell O; Möller JC; Delf M; Oertel WH Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884 [TBL] [Abstract][Full Text] [Related]
39. Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy. Binder S; Deuschl G; Volkmann J Eur Neurol; 2009; 61(3):149-53. PubMed ID: 19092251 [TBL] [Abstract][Full Text] [Related]